Search

Search Results

• The impact of GLP 1 analogues on fertility restoration in patients with Polyendocrine Metabolic Ovarian Syndrome (PMOS) - Narrative Review

  Martyna Więcławek, Magdalena Grzymek, Makary Hejduk, Joanna Kadłuczka, Weronika Kępa , Katarzyna Kraska , Aneta Sobek, Justyna Bury, Katarzyna Pawłucka , Aleksandra Pawłucka , Jan Potoniec

  74321

  2026-08-13
• The Role of GLP-1 Receptor Agonists in the Management of Polycystic Ovary Syndrome: A Narrative Review

  Angelika Juszczyk, Sylwia Pietrajtis, Bartłomiej Sałapski, Dominika Brożyna, Mateusz Kubicki, Damian Grębosz, Jakub Piec, Wiktoria Komornik, Michał Łebek, Krzysztof Lis

  74171

  2026-08-07
• The Impact of GLP-1 Receptor Agonists on Semen Parameters and the Hypothalamic–Pituitary–Gonadal Axis in Men with Obesity — A Literature Review

  Aleksandra Mliczek, Brajan Roczyński, Izabela Polok, Julia Obersztyn, Adrianna Szczecińska

  75106

  2026-09-13
• Beyond Glycemic Control: The Expanding Role of GLP-1 Analogues in Type 2 Diabetes and Metabolic Health

  Michał Mazur, Dorota Waz, Jakub Szarłowicz, Zofia Goliszek, Karolina Łucja Sobek, Wiktoria Tabin-Barczak, Aldona Sokołowska, Klaudia Fikas, Kamil Chwaliszewski, Sebastian Samuła

  56722

  2024-12-20
• Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management: Mechanisms, Efficacy, and Safety

  Michał Stasiak, Wiktor Żyro, Karolina Woźniak, Katarzyna Żyro, Franciszek Glapiński, Adam Woźniak

  60634

  2025-06-17
• Preserving Skeletal Muscle and Function During GLP-1 Receptor Agonist Therapy: An Evidence-Informed Exercise Prescription Framework

  Michał Adamczak, Marcel Majewski, Bogumił Libura, Martyna Lazar, Łukasz Szkaradowski, Szymon Baranowski, Julia Lewańska, Krzysztof Bogdański, Zuzanna Kruszyńska, Anastasiya Aleshchyk

  74482

  2026-08-11
• GLP-1 RAs and Muscle Function Outcomes in Active Adults and Athletes

  Anna Świerczek, Bartosz Zawadzki, Natalia Kornacka, Jakub Zwardoń, Katarzyna Naja, Miłosz Rewekant, Aleksander Gajkowski, Tomasz Adam Szczepanowski, Krzysztof Bednarski, Zuzanna Walczak

  73870

  2026-08-08
• Therapeutic Spectrum of GLP-1 Receptor Agonist: From Glycemic Control to Metabolic Protection

  Marta Kamińska, Wiktoria Kotlarz, Matylda Kuczma, Adrianna Klimczak, Barbara Pietrzak, Mikołaj Patelski, Maciej Czapla, Mateusz Surma, Wiktoria Mikusek, Jakub Molenda

  68001

  2026-01-17
• The Impact of GLP-1 Receptor Agonists on Body Composition and Musculoskeletal Integrity: A Review of Mechanisms, Protective Strategies, and Clinical Perspectives

  Szymon Domagała, Zuzanna Wiater, Aleksandra Włodarczyk, Karolina Brankowska, Marta Jakubowska, Michał Olejnik, Paulina Tymińska, Piotr Artur Górka, Julia Frączek, Witold Kądziołka

  69771

  2026-03-24
• GLP-1 Receptor Agonists in Recreational Athletes: Emerging Weight-Reduction Strategy or Potential Health Risk? A Review of Current Evidence

  Kamil Topolski, Wiktoria Tłoczek, Wiktoria Śliwa, Daria Twardowska, Barbara Jelonek, Barbara Tomczak, Dagmara Porada, Monika Wandasiewicz, Karolina Klubikowska, Małgorzata Wandzel

  71600

  2026-05-22
• GLP-1 receptor agonists and skeletal muscle: The risk of sarcopenic obesity and the role of resistance training. A narrative review

  Roksana Milaniuk, Aleksandra Drzewiecka, Szymon Daniszewski, Izabela Czerny, Beata Surówka, Wioleta Pluta, Krzysztof Talarowski, Piotr Tylec, Arkadiusz Ściubak, Jakub Bryl, Aleksandra Pacek

  74557

  2026-08-17
• The Impact of GLP-1 Receptor Agonists on Reproductive Function in Women with Obesity and Metabolic Disorders: A Narrative Review

  Emilia Muraszewska, Łukasz Muraszewski, Patrycja Kwitowska, Małgorzata Pyjecka, Eryk Ubysz, Agata Król, Edyta Lewandowska, Cezary Łuczyński, Maciej Paczkowski, Mariusz Wręczycki

  70814

  2026-04-19
• Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment

  Łukasz Zdziebkowski, Hanna Wilska, Dorota Szatkowska, Dominika Ziętara, Kacper Kmieć, Aleksandra Topolska, Marcin Komorowski, Michał Janiszewski, Natalia Surosz, Michał Grochowalski, Aleksandra Graczyk, Jakub Szydło

  62342

  2025-07-14
• GLP-1 Receptor Agonists Beyond Metabolic Control: Cardiovascular Benefits, Renal Protection, Neurological Effects and Socioeconomic Implications of Widespread Use.

  Weronika Wrona, Anna Wojdas , Wiktoria Wdowiak , Małgorzata Dorożalska , Małgorzata Jurczyk , Aleksandra Glapa , Hanna Ludwisiak , Maja Cwalina, Julia Owsik , Weronika Ryś

  76169

  2026-10-02
• GLP-1 Receptor Agonists: Therapeutic Benefits in Renal Function, Cardiovascular Risk, and Physical Activity - A Systematic Review

  Łukasz Karaban, Tadeusz Kuźnieców, Monika Paszkowska, Klaudia Mularczyk, Michał Borawski, Aleksandra Ciuła, Anna Jakubiak, Joanna Miśkiewicz, Patrycja Znamirowska, Magdalena Kupis

  60343

  2025-05-09
• The Influence of GLP-1 Receptor Agonists on Wound Healing After Surgery: What Current Evidence Tells Us

  Karolina Fengler, Katarzyna Solecka, Agata Urbanik, Olga Jakubowska, Dominika Kominiak, Zuzanna Oćwieja, Agata Wyborska, Kamila Pietrzak, Mikołaj Mińkowski, Marcel Gascon Carreno

  73196

  2026-07-08
• The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review

  Kamil Turlej, Dmytro Kowalczuk, Viktoryia Kasianik, Darya Lazitskaya, Mykola Sobchynskyi, Valeryia Milasheuskaya, Andrii Myrnyi, Iga Kiełbaszewska, Natallia Surosz, Katsiaryna Miraniuk

  61264

  2025-07-07
• Dietary Modulation and Clinical Outcomes During GLP-1 Receptor Agonist Therapy. A Literature Review

  Kacper Rychlica, Konrad Gawin, Wiktoria Zawiślak, Anita Ignasiak, Michał Cisowski, Maria Dąbrowska, Jolanta Cholewińska-Rychlica, Paulina Madura, Daria Mrozik-Gałecka

  67649

  2026-01-18
• Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?

  Małgorzata Blecharczyk, Aleksandra Jakimowicz, Zuzanna Zofia Kamińska, Aleksandra Malcher, Martyna Mrozek, Martyna Pacanowska-Trawnicka, Agnieszka Zielińska, Igor Zydlewski

  72512

  2026-05-30
• Synergistic Role of Creatine Monohydrate in Mitigating Skeletal Muscle Wasting and Strength Decline during GLP-1 Receptor Agonist Therapy: A Comperhensive Review

  Aladdin Salama, Shafea Abdulla, Anhelina Kaminskaya, Sofiia Ivanchuk, Tetiana Savchak, Aleksandra Kurek, Dominika Domińczak, Patryk Górecki, Aleksandra Głowacka, Hubert Feretycki

  70226

  2026-04-04